Back to results
US 11,883,393 B2Granted
Compounds and methods for the targeted degradation of androgen receptor
AssigneeArvinas Operations, Inc.
InventorsLawrence B. Snyder, Hanqing Dong
Life of this patent
Estimating the term…
Abstract
This disclosure pertains to compounds, the preparation thereof, and the use of these compounds in the treatment of prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in subjects in need thereof.
Claims4
A compound that is:
A pharmaceutically acceptable salt of a compound that is:
A pharmaceutical composition comprising a compound and one or more pharmaceutically acceptable excipients, wherein the compound is:
A pharmaceutical composition comprising a pharmaceutically acceptable salt of a compound and one or more pharmaceutically acceptable excipients, wherein the compound is:
Dependencies are inferred from the claim text.